Refacto TerminalKalshi
AdvertisementYour banner here · 728 × 90 · ads@refacto.app

← Explore · Kalshi · Market KXFDAVERVE102-VERV-33JAN01

Will the FDA approve VERVE-102 before Jan 1, 2033?

75.0% implied · bid 71.0¢ · ask 79.0¢

☆ Log in to track

A · Price & probability

The market prices this at 75.0%, down 0.5pt over 24h, on a 8.0¢ spread.

Implied probability75.0%
Bid / ask / mid71.0¢ / 79.0¢ / 75.0¢
Spread8.0¢ (10.7%)
Change 24h-0.50pt
Change 7d+0.00pt

B · Liquidity & flow

Thin (score 10/100) — trade small; large orders will move the price. Order book leans 23% to the ask (sellers).

Volume 24h$0
Depth ±5¢ (bid/ask)$355 / $395
Imbalance23% bid
Large trades (>$1k)0
Liquidity score10.4 / 100

C · Momentum & volatility

RSI 50 (neutral); price is above its 7-day mean by 0.1σ — normal range.

Z-score vs 7d mean0.10
RSI (14, hourly)49.5
Realized vol 7d5.72pt
Change 1h+0.00pt

E · Time & structure

Resolves in 3040d 5h.

Time to resolve3040d 5h
Resolution sourcemanual-review
Sum of outcomes100.0%

Price history

Probability timeline

Order-book depth